Comparison of ramosetron's and ondansetron's preventive anti-emetic effects in highly susceptible patients undergoing abdominal hysterectomy

Korean Journal of Anesthesiology

Volumn 61, Issue 6, 2011, Pages 488-492

  Lee, Jae Woo ^a   Park, Hyejin ^a   Choi, Juyoun ^a   Park, So Jin ^a   Kang, Hyoseok ^a   Kim, Eu Gene ^a  

^a Eulji General Hospital   (South Korea)

Author keywords

Abdominal hysterectomy; Ondansetron; PONV; Ramosetron

Indexed keywords

FENTANYL; KETOROLAC; NARCOTIC ANALGESIC AGENT; ONDANSETRON; PROPOFOL; RAMOSETRON; VECURONIUM;

ABDOMINAL HYSTERECTOMY; ANTIEMETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; HEADACHE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; PATIENT CONTROLLED ANALGESIA; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

EID: 84855318566     PISSN: 20056419     EISSN: 20057563     Source Type: Journal    
DOI: 10.4097/kjae.2011.61.6.488     Document Type: Article

References (19)

1. Watcha MF, White PF. Postoperative nausea and vomiting. Its etiology, treatment and prevention. Anesthesiology 1992; 77: 162-84.
2. Apfel CC, Läärä E, Koivuranta M, Greim CA, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology 1999; 91: 693-700.
3. Sinclair DR, Chung F, Mezei G. Can postoperative nausea and vomiting be predicted? Anesthesiology 1999; 91: 109-18.
4. Kovac AL. Prevention and treatment of postoperative nausea and vomiting. Drugs 2000; 59: 213-43.
5. Gan TJ. Selective serotonin 5-HT3 receptor antagonists for postoperative nausea and vomiting: are they all the same? CNS Drugs 2005; 19: 225-38.
6. Jenkins LC, Lahay D. Central mechanisms of vomiting related to catecholamine response: anaesthetic implication. Can Anaesth Soc J 1971; 18: 434-41.
7. Tramer MR, Reynolds DJ, Moore RA, McQuay HJ. Efficacy, doseresponse, and safety of ondansetron in prevention of postoperative nausea and vomiting: a quantitative systematic review of randomized placebo-controlled trials. Anesthesiology 1997; 87: 1277-89.
8. Rabasseda X. Ramosetron, a 5-HT3 receptor antagonist for the control of nausea and vomiting. Drugs Today (Barc) 2002; 38: 75-89.
9. Hirata T, Keto Y, Funatsu T, Akuzawa S, Sasamata M. Evaluationof the pharmacological profile of ramosetron, a novel therapeutic agent for irritable bowel syndrome. J Pharmacol Sci 2007; 104: 263-73.
10. Ayuhara H, Takayanagi R, Okuyama K, Yoshimoto K, Ozeki T, Yokoyama H, et al. Receptor occupancy theory-based analysis of interindividual differences in antiemetic effects of 5-HT3 receptor antagonists. Int J Clin Oncol 2009; 14: 518-24.
11. Choi YS, Shim JK, Yoon do H, Jeon DH, Lee JY, Kwak YL. Effect of ramosetron on patient-controlled analgesia related nausea and vomiting after spine surgery in highly susceptible patients. Spine (Phila Pa 1976) 2008; 33: E602-6.
12. Shi Y, He X, Yang S, Ai B, Zhang C, Huang D, et al. Ramosetron versus ondansetron in the prevention of chemotherapy-induced gastrointestinal side effects: A prospective randomized controlled study. Chemotherapy 2007; 53: 44-50.
13. Hahm TS, Ko JS, Choi SJ, Gwak MS. Comparison of the prophylactic anti-emetic efficacy of ramosetron and ondansetron in patients at high-risk for postoperative nausea and vomiting after total knee replacement. Anaesthesia 2010; 65: 500-4.
14. Fujii Y, Saitoh Y, Tanaka H, Toyooka H. Comparison of ramosetron and granisetron for preventing postoperative nausea and vomiting after gynecologic surgery. Anesth Analg 1999; 89: 476-9.
15. Eisenach JC, Grice SC, Dewan DM. Patients-controlled analgesia following cesarean section: A comparison with epidural and intramuscular narcotics. Anesthesiology 1988; 68: 444-8.
16. Ryu J, So YM, Hwang J, Do SH. Ramosetron versus ondansetron for the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy. Surg Endosc 2010; 24: 812-7.
17. Kim SI, Kim SC, Baek YH, Ok SY, Kim SH. Comparison of ramosetron with ondansetron for prevention of postoperative nausea and vomiting in patients undergoing gynaecological surgery. Br J Anaesth 2009; 103: 549-53.
18. Pan PH, Lee SC, Harris LC. Antiemetic prophylaxis for postdischarge nausea and vomiting and impact on functional quality of living during recovery in patients with high emetic risks: A prospective, randomized, double-blind comparison of two prophylactic antiemetic regimens. Anesth Analg 2008; 107: 429-38.
19. Andrews PL, Bhandari P, Davey PT, Bingham S, Marr HE, Blower PR. Are all 5-HT3 receptor antagonists the same? Eur J Cancer 1992; 28A Suppl 1: S2-6.